Rights and permissions
About this article
Cite this article
US FDA guidance requires pharmaceutical companies to integrate race and ethnicity data into clinical trial analyses. Inpharma Wkly. 1373, 3 (2003). https://doi.org/10.2165/00128413-200313730-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200313730-00004